Variations in the Occurrence of Specific RpoB Mutations in Rifampicin-resistant Mycobacterium Tuberculosis Isolates from Patients of Different Ethnic Groups in Kuwait
Overview
Affiliations
Background & Objectives: Frequency of resistance-conferring mutations vary among isoniazid- and ethambutol-resistant Mycobacterium tuberculosis isolates obtained from patients of various ethnic groups. This study was aimed to determine the occurrence of specific rpoB mutations in rifampicin-resistant M. tuberculosis isolates from tuberculosis patients of various ethnic groups in Kuwait.
Methods: Rifampicin-resistant M. tuberculosis isolates (n=119) from South Asian (n=55), Southeast Asian (n=23), Middle Eastern (n=39) and other (n=2) patients and 107 rifampicin-susceptible isolates were tested. Mutations in rpoB were detected by DNA sequencing. Polymorphisms at katG463 and gyrA95 were detected by PCR-RFLP for genetic group assignment.
Results: None of rifampicin-susceptible but 116 of 119 rifampicin-resistant isolates showed rpoB mutation(s). Mutations among isolates from South Asian patients were distributed at rpoB516 (20%), rpoB526 (24%) and rpoB531 (27%) while 78 and 51 per cent of isolates from Southeast Asian and Middle Eastern patients, respectively, contained a mutated rpoB531. All isolates with rpoB N-terminal and cluster II mutations were obtained from Middle Eastern and South Asian patients. Most isolates from South Asian (84%) and Southeast Asian (70%) patients belonged to genetic group I while nearly all remaining isolates belonged to genetic group II. Isolates from Middle Eastern patients were distributed among genetic group I (46%), genetic group II (33%) and genetic group III (21%).
Interpretation & Conclusions: The occurrence of specific rpoB mutations varied considerably in rifampicin-resistant M. tuberculosis isolates obtained from patients of different ethnic groups within the same country. The present data have important implications for designing region-specific rapid methods for detecting majority of rifampicin-resistant strains.
Al-Mutairi N, Ahmad S, Mokaddas E, Al-Hajoj S PLoS One. 2022; 17(10):e0276487.
PMID: 36264939 PMC: 9584360. DOI: 10.1371/journal.pone.0276487.
Emerging Status of Multidrug-Resistant Bacteria and Fungi in the Arabian Peninsula.
Borgio J, Rasdan A, Sonbol B, Alhamid G, Almandil N, AbdulAzeez S Biology (Basel). 2021; 10(11).
PMID: 34827138 PMC: 8614875. DOI: 10.3390/biology10111144.
Leehan J, Nicholson W Appl Environ Microbiol. 2021; 87(22):e0123721.
PMID: 34495706 PMC: 8552901. DOI: 10.1128/AEM.01237-21.
Iqbal J, Ahmad S, Sher A, Al-Awadhi M Microorganisms. 2021; 9(7).
PMID: 34361867 PMC: 8307262. DOI: 10.3390/microorganisms9071431.
Al-Mutairi N, Ahmad S, Mokaddas E Sci Rep. 2021; 11(1):7765.
PMID: 33833390 PMC: 8032671. DOI: 10.1038/s41598-021-87516-0.